Administer Sliding-Scale Correctional Insulin Subcutaneously (SQ), Not Intravenously (IV)
For a typical 70-kg adult on a basal-plus insulin regimen in a non-critical care setting, sliding-scale correctional insulin should be given subcutaneously (SQ). IV insulin infusions are reserved exclusively for critically ill patients, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), or severe DKA requiring intensive care 1.
Route Selection Algorithm
Give SQ Correctional Insulin When:
- Patient is on a general medical/surgical floor (non-ICU)
- Patient is on a basal-plus regimen (basal insulin 0.1-0.25 U/kg/day + correctional doses)
- Blood glucose elevations are mild to moderate
- Patient is hemodynamically stable
- No active DKA/HHS
Give IV Insulin Infusion When:
- Patient is critically ill in ICU
- Severe DKA or HHS present
- Hemodynamic instability
- Need for rapid, titratable glucose control
Clinical Reasoning
The guidelines are explicit that subcutaneous insulin regimens are the standard for non-critically ill hospitalized patients 1, 2. The basal-plus approach specifically consists of once-daily basal insulin (typically 0.1-0.25 U/kg/day) combined with subcutaneous rapid-acting insulin given as correctional doses before meals or every 6 hours if NPO 1.
IV insulin infusions are physiologically inappropriate for stable ward patients because:
Pharmacokinetics: IV insulin has an extremely rapid onset (peak at 2 minutes) and short duration (3.5 hours to baseline), causing dramatic glucose swings 3. SQ insulin provides more physiologic absorption with peak at 60-90 minutes and sustained effect over 6 hours 3.
Safety Profile: The basal-plus approach with SQ correctional insulin reduces hypoglycemia risk compared to more intensive regimens while maintaining adequate glycemic control 1. Recent evidence shows SQ regimens in appropriate patients have fewer hypoglycemic events than IV protocols 4.
Resource Utilization: IV insulin requires ICU-level monitoring with hourly glucose checks and continuous nursing oversight. SQ insulin allows safe management on general wards 5, 4.
Common Pitfalls to Avoid
Do not confuse "sliding scale" terminology with route of administration. The term "sliding scale" refers to reactive dosing based on current glucose values, not the delivery method. Modern correctional insulin is always given SQ in non-critical patients as part of a basal-plus or basal-bolus regimen 1, 2.
Do not use IV insulin outside the ICU setting unless the patient has DKA/HHS or is critically ill requiring intensive monitoring. The evidence shows no benefit and increased resource burden 1, 5.
Do not use sliding-scale insulin alone as monotherapy—this outdated practice leads to poor glycemic control 1, 6. Always combine correctional doses with scheduled basal insulin in the basal-plus approach for patients with mild hyperglycemia or decreased oral intake 1.
Practical Implementation
For your 70-kg patient on basal-plus:
- Basal insulin: 7-17.5 units once daily (0.1-0.25 U/kg) given SQ
- Correctional insulin: Rapid-acting insulin SQ before meals or every 6 hours if NPO, using a correction scale (typically 1-2 units per 50 mg/dL above 150 mg/dL, adjusted for insulin sensitivity)
- Monitoring: Pre-meal and bedtime glucose checks (4 times daily minimum)
The 2022 Endocrine Society guidelines confirm this approach, recommending correctional insulin with or without scheduled insulin for non-critically ill patients, with all insulin given subcutaneously 2.